Bis-pyrazole as receptor interacting protein 1 kinase inhibitor: Synthesis, preliminary biological evaluation against pancreatic cancer cell line and its docking studies

The pyrazole heterocycle displayed versatile pharmacological activity ranging from anti-inflammatory to antiviral. Herein, we report the synthesis of bis-pyrazole as receptor- interacting protein 1 kinase inhibitor and evaluated for antiproliferative activity against pancreatic cancer line, PANC-1....

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sandeep Singh, Rajeev Kumar Sharma, R. Ramajayam
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-01-01
Edice:	Results in Chemistry
Témata:	Pyrazole Antiproliferative RIP 1 kinase inhibitor Pancreatic cancer
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2211715624001437
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!